2BB score and signals
Vanda Pharmaceuticals Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 67 | High |
| Momentum | 71 | Improving |
| Financial strength | 24 | Weak |
| Quality | 99 | Very Strong |
| Risk | 48 | Moderate |
Company facts
| Headquarters | Washington, Washington, United States |
| Founded | 2002 |
| Employees | 533 |
| 52-week range | $4.20 – $9.94 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-09 | — | -0.5039 | — | $78.96M |
| 2026-11-04 | — | -0.6956 | — | $70.59M |
| 2026-08-05 | — | -0.5993 | — | $63.16M |
| 2026-05-06 | -0.82 | -0.7018 | $51.72M | $56.08M |
Related companies
2BBBullish & Bearish